NICE guidance: why not clozapine for treatment-refractory bipolar disorder? - Authors' reply.
Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham, Nottingham NG7 2UH, UK. Electronic address: richard.morriss@nottingham.ac.uk.
Richard
R
Morriss
Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Evan
E
Mayo-Wilson
National Collaborating Centre for Mental Health, London, UK; Sheffield Health and Social Care National Health Service Foundation Trust, Sheffield, UK.
Tim
T
Kendall